[Respiratory changes during treatment with bleomycin].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012140:Respiratory Tract Diseases / Q000139:chemically induced*; D012141:Respiratory Tract Infections / Q000139:chemically induced / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D001761:Bleomycin
Manifestations pneumologiques au cours de traitements par la bléomycine.